AU8604598A - Pharmaceutical formulation for camptothecin analogues in gelatin capsule - Google Patents
Pharmaceutical formulation for camptothecin analogues in gelatin capsuleInfo
- Publication number
- AU8604598A AU8604598A AU86045/98A AU8604598A AU8604598A AU 8604598 A AU8604598 A AU 8604598A AU 86045/98 A AU86045/98 A AU 86045/98A AU 8604598 A AU8604598 A AU 8604598A AU 8604598 A AU8604598 A AU 8604598A
- Authority
- AU
- Australia
- Prior art keywords
- pharmaceutical formulation
- gelatin capsule
- camptothecin analogues
- camptothecin
- analogues
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US90476197A | 1997-08-01 | 1997-08-01 | |
US08904761 | 1997-08-01 | ||
PCT/US1998/015908 WO1999006031A1 (en) | 1997-08-01 | 1998-07-30 | Pharmaceutical formulation for camptothecin analogues in gelatin capsule |
Publications (1)
Publication Number | Publication Date |
---|---|
AU8604598A true AU8604598A (en) | 1999-02-22 |
Family
ID=25419727
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU86045/98A Abandoned AU8604598A (en) | 1997-08-01 | 1998-07-30 | Pharmaceutical formulation for camptothecin analogues in gelatin capsule |
Country Status (5)
Country | Link |
---|---|
AR (1) | AR013261A1 (en) |
AU (1) | AU8604598A (en) |
CO (1) | CO4970695A1 (en) |
WO (1) | WO1999006031A1 (en) |
ZA (1) | ZA986877B (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6281223B1 (en) | 1999-04-13 | 2001-08-28 | Supergen, Inc. | Radioenhanced camptothecin derivative cancer treatments |
GB9918885D0 (en) * | 1999-08-10 | 1999-10-13 | Pharmacia & Upjohn Spa | Pharmaceutical formulations in hydroxypropymethycellulose capsules |
AU2005222541B2 (en) * | 1999-08-10 | 2008-07-24 | Pharmacia & Upjohn S.P.A. | Pharmaceutical formulations in hydroxypropylmethylcellulose capsules |
GB9925127D0 (en) * | 1999-10-22 | 1999-12-22 | Pharmacia & Upjohn Spa | Oral formulations for anti-tumor compounds |
AR046579A1 (en) | 2003-11-12 | 2005-12-14 | Smithkline Beecham Corp | TOPOTECAN CRYSTAL COMPOSITE, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT, PROCEDURE TO PREPARE IT AND ITS USE TO PREPARE SUCH PHARMACEUTICAL COMPOSITION |
GT200500310A (en) | 2004-11-19 | 2006-06-19 | ORGANIC COMPOUNDS | |
SA06270147B1 (en) | 2005-06-09 | 2009-12-22 | نوفارتيس ايه جي | Process for the Synthesis Of 5-(methyl-1h-imidazol-1-yl)-3-(trifluoromethyl)-benzenamine |
ITRM20050418A1 (en) * | 2005-08-04 | 2007-02-05 | Sigma Tau Ind Farmaceuti | IMMEDIATE RELEASE THERAPEUTIC SYSTEMS FOR THE IMPROVED ORAL ABSORPTION OF 7 - [(E) -T-BUTYLOSSIMINOMETHYL] CAMPTOTECIN. |
RU2597841C2 (en) * | 2010-12-20 | 2016-09-20 | Колгейт-Палмолив Компани | Non-aqueous oral care composition containing active agents for dental occlusion |
SG190860A1 (en) | 2010-12-20 | 2013-07-31 | Colgate Palmolive Co | Gelatin encapsulated oral care composition containing dental occlusion actives, hydrophobic viscosity modifier and oil carrier |
WO2012087280A2 (en) * | 2010-12-20 | 2012-06-28 | Colgate-Palmolive Company | Gelatin encapsulated oral care composition containing hydrophilic active, hydrophobic structuring agent and oil carrier |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8904182D0 (en) * | 1989-02-23 | 1989-04-05 | Glaxo Canada | Pharmaceutical compositions |
US5225404A (en) * | 1989-11-06 | 1993-07-06 | New York University | Methods of treating colon tumors with tumor-inhibiting camptothecin compounds |
US5468754A (en) * | 1994-04-19 | 1995-11-21 | Bionumerik Pharmaceuticals, Inc. | 11,7 substituted camptothecin derivatives and formulations of 11,7 substituted camptothecin derivatives and methods for uses thereof |
US5677286A (en) * | 1995-04-27 | 1997-10-14 | The University Of Michigan | Glycosylated analogs of camptothecin |
-
1998
- 1998-07-28 AR ARP980103700A patent/AR013261A1/en unknown
- 1998-07-30 AU AU86045/98A patent/AU8604598A/en not_active Abandoned
- 1998-07-30 WO PCT/US1998/015908 patent/WO1999006031A1/en active Application Filing
- 1998-07-31 CO CO98043769A patent/CO4970695A1/en unknown
- 1998-07-31 ZA ZA986877A patent/ZA986877B/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA986877B (en) | 1999-06-15 |
AR013261A1 (en) | 2000-12-13 |
CO4970695A1 (en) | 2000-11-07 |
WO1999006031A1 (en) | 1999-02-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9519363D0 (en) | Pharmaceutical formulation | |
ZA982872B (en) | Pharmaceutical formulation | |
HUP0100179A3 (en) | Imidazopyrimidine and imidazopyridine derivatives and pharmaceutical compositions thereof | |
AU7375598A (en) | Stable oral pharmaceutical dosage forms | |
IL124214A (en) | Stable freeze-dried pharmaceutical formulation | |
HUP0100178A3 (en) | Tetrahydro-naphtiridinyl-imidazolydinyl-carboxylic acid derivatives and pharmaceutical compositions thereof | |
AU9224498A (en) | Matrix for controlled delivery of highly soluble drugs | |
HUP0004534A3 (en) | Pharmaceutical formulation containing olanzapine | |
EP0862431A4 (en) | Pharmaceutical formulation | |
HUP9903935A3 (en) | Pharmaceutical compositions with vitamin d analogues | |
AU7454698A (en) | Improvement in medicament administration system | |
AU8604598A (en) | Pharmaceutical formulation for camptothecin analogues in gelatin capsule | |
HUP0100085A3 (en) | Biphenylamidine derivatives and pharmaceutical compositions containing them | |
IL134538A (en) | Lactacystin derivatives and pharmaceutical compositions containing the same | |
GB9918885D0 (en) | Pharmaceutical formulations in hydroxypropymethycellulose capsules | |
ZA982073B (en) | Pharmaceutical preparation | |
AU6940998A (en) | Phospholipid drug derivatives | |
GB9523566D0 (en) | Pharmaceutical formulation | |
IL132986A0 (en) | Rapamycin formulation for oral administration | |
AU3953197A (en) | Catechol amino acid derivatives and pharmaceutical compositions containing them | |
GB9709739D0 (en) | Pharmaceutical formulation | |
ZA981775B (en) | Pharmaceutical formulations containing poorly soluble drug substances | |
AU3860797A (en) | Pharmaceutical formulations for oral administration | |
HUP0004132A3 (en) | Rapidly soluble drug composition | |
AU5182099A (en) | Pharmaceutical formulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |